{"id":"W4413117443","doi":"10.1016/j.ejim.2025.07.020","title":"A person-centred clinical approach to the multimorbid patient with COPD","year":2025,"lang":"en","type":"article","venue":"European Journal of Internal Medicine","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"National Heart, Lung, and Blood Institute; Medical Research Council; Novartis Pharma; Mereo BioPharma; AOP Orphan; Swedish Orphan Biovitrum; Galápagos; Moderna; Pfizer; Incyte; Insmed; ResMed; Genentech; Veracyte; Amicus Therapeutics; Cerecor; Regeneron Pharmaceuticals; Intuitive Surgical; Bayer; Gilead Sciences; Sanofi; COPD Foundation; United Therapeutics Corporation; Massachusetts General Hospital; Lung Foundation Australia; GlaxoSmithKline; National Institute for Health and Care Research; CSL Behring; Chiesi Farmaceutici; Eli Lilly and Company; AstraZeneca; Patient-Centered Outcomes Research Institute; Pulmonary Fibrosis Foundation; Amgen; NGM Biopharmaceuticals","keywords":"Medicine; COPD; Comorbidity; Multimorbidity; Intensive care medicine; Quality of life (healthcare); Disease; MEDLINE; Disease management; Delphi method; Disease burden; Physical therapy; Internal medicine; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001367879,0.0002375374,0.0005988094,0.0003159877,0.00008426605,0.00002421301,0.0005581135,0.00002619393,0.0002670951],"category_scores_gemma":[0.001238228,0.0001164738,0.0002230759,0.0004091473,0.0004332187,0.00006302848,0.0001490927,0.001080172,0.00007042642],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000232968,"about_ca_system_score_gemma":0.0003076308,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003038235,"about_ca_topic_score_gemma":0.000001876308,"domain_scores_codex":[0.9966713,0.0007382386,0.0009469565,0.0003113503,0.0009768558,0.0003552528],"domain_scores_gemma":[0.9976088,0.0002447039,0.000365884,0.0004503885,0.0007098941,0.0006203076],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.02416625,0.002874503,0.09222322,0.0006103868,0.002925918,0.01689785,0.00941899,0.0001585815,0.0009841057,0.0003272999,0.4248797,0.4245332],"study_design_scores_gemma":[0.02218408,0.009662631,0.6849419,0.008638273,0.0009504752,0.006565286,0.02082367,0.002125053,0.0001712342,0.0000120362,0.2435793,0.0003461116],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7046727,0.006304063,0.00989996,0.03602793,0.001917645,0.001230198,0.00001293449,0.0000383761,0.2398962],"genre_scores_gemma":[0.9885082,0.00008290695,0.001699045,0.005132859,0.001464902,0.000003351819,0.000003508912,0.00004100758,0.003064241],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5927187,"threshold_uncertainty_score":0.4749666,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05202035915197409,"score_gpt":0.3305998123753949,"score_spread":0.2785794532234208,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}